FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month
source: pixabay.com

FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month

By May 25th, 2021 the FDA will announce their decision regarding approval of Opdivo used in combination with chemotherapy for gastrointestinal cancers. Back in December, Priority Review was granted to…

Continue Reading FDA Decision on Opdivo with Chemotherapy for Advanced Gastrointestinal Cancers will be Made Next Month
ICYMI: Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
DarkoStojanovic / Pixabay

ICYMI: Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

According to a publication from EurekAlert, a recent study helmed by the Royal Marsden NHS Foundation Trust suggests that female cancer patients tend to live slightly longer following treatment than…

Continue Reading ICYMI: Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
DarkoStojanovic / Pixabay

Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

According to a publication from EurekAlert, a recent study helmed by the Royal Marsden NHS Foundation Trust suggests that female cancer patients tend to live slightly longer following treatment than…

Continue Reading Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

New Treatment Approved by FDA for Rare Form of Hepatocellular Carcinoma

The FDA has just recently approved CYRAMZA as a treatment for those with hepatocellular carcinoma (HCC), who have been treated with sorafenib, and who have ≥400 ng/mL of alpha-fetoprotein (AFP).…

Continue Reading New Treatment Approved by FDA for Rare Form of Hepatocellular Carcinoma
Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer
Free-Photos / Pixabay

Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer

An investigational drug called ALT-P7 is being developed as a potential medicine for certain forms of cancer. The drug has received Orphan Drug Designation for the treatment of gastric cancer…

Continue Reading Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer
New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus
source: pixabay.com

New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus

According to an article from VCU Massey Center's blog, a team of researchers from the VCU Massey Cancer Center have successfully discovered a pair of genes that could be essential for…

Continue Reading New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus